Trials / Conditions / Pars Plana Vitrectomy

Pars Plana Vitrectomy

13 registered clinical trials studyying Pars Plana Vitrectomy — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	INTRAOCULAR PRESSURE MEASUREMENT AT the END of PARS PLANA VITRECTOMY NCT06707168	Sunnybrook Health Sciences Centre	N/A
Terminated	Necessity of Post-operative Eye Drops NCT07396831	Loma Linda University	—
Recruiting	Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment NCT05728476	Tianjin Medical University Eye Hospital	N/A
Withdrawn	Safety and Efficacy of HydroLenz for Vitrectomy-Induced Lens Opacities NCT05592912	PromiSight, LLC	Phase 1
Unknown	Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients NCT05990829	Tianjin Medical University Eye Hospital	Phase 4
Unknown	Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patie NCT05631054	Tianjin Medical University Eye Hospital	—
Completed	Effectiveness and Safety of 25-Gauge Needle-Assisted Phacoemulsification of Dislocated Intravitreal Lens Nucle NCT06709378	Changzhou No.2 People's Hospital	—
Unknown	A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabeti NCT05248334	Tianjin Medical University Eye Hospital	Phase 1
Unknown	Quantification of Silicone Oil Emulsification After Pars Plana Vitrectomy NCT04774146	Ospedale Policlinico San Martino	—
Completed	Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy NCT04278079	Tanta University	N/A
Completed	Suprachoroidal Hemorrhage Associated With Pars Plana Vitrectomy NCT05013281	Beijing Tongren Hospital	—
Terminated	SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy NCT00936520	Johns Hopkins University	Phase 1
Completed	Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment NCT00548197	Iran University of Medical Sciences	Phase 1